Svizera Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -0.07%
- Profit Growth -5.94%
- Ebitda -10.29%
- Net Worth 2.82%
- Total Assets 3.86%
About Svizera Pharma
Svizera Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 April 2000 and has a history of 24 years and ten months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Maneesh Sapte and Vinay Sapte serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH2000PTC126087
- Company No.
126087
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2000
- Date of AGM
11 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Svizera Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maneesh Sapte  | Director | 24-Apr-2000 | Current |
| Vinay Sapte | Director | 24-Apr-2000 | Current |
Financial Performance of Svizera Pharma.
Svizera Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.07% decrease. The company also saw a slight decrease in profitability, with a 5.94% decrease in profit. The company's net worth moved up by a moderate rise of 2.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Svizera Pharma?
In 2023, Svizera Pharma had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Phaarmasia LimitedManeesh Sapte and Vinay Sapte are mutual person
Ergos Life Sciences Private LimitedVinay Sapte is a mutual person
Svizera Health Remedies LlpManeesh Sapte and Vinay Sapte are mutual person
Maneesh Pharmaceuticals LimitedManeesh Sapte and Vinay Sapte are mutual person
Adhrit Education LlpManeesh Sapte and Vinay Sapte are mutual person
- Pharmanova Specialties Private Limited
Maneesh Sapte and Vinay Sapte are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Svizera Pharma?
Unlock and access historical data on people associated with Svizera Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svizera Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svizera Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
